EVGN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:46):

Stats
Today's Volume	57 547.00
Average Volume	159 820
Market Cap	31.49M
EPS	$0 ( 2024-03-07 )
Next earnings date	( $-0.0700 ) 2024-05-16
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.200
ATR14	$0.00800 (1.28%)

Evogene Ltd Correlation

10 Most Positive Correlations
PSTX	0.926
AVDX	0.922
MULN	0.913
NESR	0.909
PRAX	0.907
OM	0.901
ENTA	0.901
UBFO	0.9
MPAA	0.899
TKNO	0.894

10 Most Negative Correlations
EPZM	-0.922
CNCE	-0.906
XOG	-0.898
LMNL	-0.869
TLMD	-0.868
TYHT	-0.867
RESN	-0.862
SIVBP	-0.85
CNST	-0.849
FIZZ	-0.847

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evogene Ltd Correlation - Currency/Commodity

0.65
( moderate )

0.68
( moderate )

0.00
( neutral )

-0.63
( weak negative )

Evogene Ltd Financials

Annual	2023
Revenue:	$5.64M
Gross Profit:	$1.40M (24.80 %)
EPS:	$-0.520

FY	2023
Revenue:	$5.64M
Gross Profit:	$1.40M (24.80 %)
EPS:	$-0.520

FY	2022
Revenue:	$1.68M
Gross Profit:	$766 000 (45.73 %)
EPS:	$-0.720

FY	2021
Revenue:	$930 000
Gross Profit:	$163 000 (17.53 %)
EPS:	$-0.690

Financial Reports:

No articles found.

Evogene Ltd

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.